Special Winter 2025Preview: Drug Delivery ServicesAlthough smart drug delivery accounts for only 10% of drug development costs, significant efforts have been made to optimise drug properties such as solubility, stability and release kinetics, while … more ➔
Special Winter 2025Preview: Talent scouting & educationFaced with a severe shortage of skilled labour, specialised biopharma companies and service providers such as CROs and CDMOs are competing globally for the best minds. Active recruitment and retention … more ➔
Special Winter 2025Preview: Automation in quality controlBy modelling the (bio)manufacturing processes digitally, companies can simulate different conditions, optimise parameters, and improve efficiency without disrupting actual production. Using a simulation … more ➔
Special Autumn 2025Preview: CROs & CDMOsCDMOs and CROs are under great pressure to integrate new trial designs and drug formats – including ATMPs, ADCs, condensate blockers, RNA drugs and formulations as well as automated preclinical testing … more ➔
Special Autumn 2025Preview: Automation & data scienceEuropean Biotechnology Magazine’s comprehensive special feature ‘Lab automation & data sciences/AI’, created in cooperation with the Society for Laboratory Automation and Screening (SLAS), provides … more ➔
Special Autumn 2025Preview: ADCs & beyondAntibody-drug conjugates and targeted radiopharmaceuticals promised chemotherapies and radiotherapies with fewer side effects by delivering cytotoxic cargos more specifically to the site of action, usually … more ➔
Special Summer 2025Preview: (Bio)EngineeringUsing engineered organisms for chemical manufacturing was the initial foundation motivation for Genentech in 1976 in South San Francisco. However, pharmaceutical manufacturing in recombinant bacteria … more ➔
Special Summer 2025Preview: Clusters + ManufacturingAs the European biotech ecosystem is increasingly maturing compared to competitors from Asia and the US, European Biotechnology Magazine takes a closer look at the relevant but also specialised life … more ➔
Special Summer 2025Preview: New ModalitiesHot topics in automated screening and expression of new modalities: Whether antibody conjugates (ADCs or radiopharmaceuticals), T-cell, NK-cell or MAIT engagers, bispecific checkpoint inhibitors, molecular … more ➔
Special Spring 2025Preview: Legal, Tax + AccountingIP, market studies, finance expertise: Companies need external expertise from consulting firms and commercial law firms. For biotech start-ups, IP rights and good legal advice are often the only assets … more ➔
